Every year, there are an estimated 20 million hepatitis E virus (HEV) infections worldwide,
leading to an estimated 3.3 million symptomatic cases of hepatitis E. HEV is largely …

Over the last decade the seroprevalence of immunoglobulin (IgG) anti hepatitis E virus
(HEV) has been increasing in European countries and shows significant variability among …

Hepatitis E virus (HEV) is the main cause of acute viral hepatitis worldwide. Its presence in
developing countries has been documented for decades. Developed countries were …

Background Notified cases of hepatitis E have increased 40-fold in the past 10 years in
Germany. Food safety is a major concern as hepatitis E virus (HEV) RNA has been detected …

Based on the worldwide distribution of hepatitis E virus (HEV) and its ability to cause major
epidemics in low-income countries, the global availability of a HEV vaccine is a pressing …

BACKGROUND Hepatitis E virus (HEV) infection is underdiagnosed due to the use of
serological assays with low sensitivity. Although most patients with HEV recover completely …

The landscape of chronic liver disease has drastically changed over the past 20 years,
largely due to advances in antiviral therapy and the rise of metabolic syndrome and …

Infection with the hepatitis E virus (HEV) is one of the main ubiquitous causes for developing
an acute hepatitis. Moreover, chronification plays a predominant role in …

Background The hepatitis E virus (HEV) represents a major cause of acute hepatitis
worldwide. The majority of HEV cases occur in low-income countries, mainly Asia and Africa …

Hepatitis E outbreaks are a serious public health concern in developing countries. The
disease causes acute infections, primarily in young adults. The mortality rate is …